The NYC Health Department has released its 2016 Hepatitis B and C Annual Report, and this past year amended the Health Code to improve complete hepatitis C diagnostic testing and outcomes in NYC.
This report presents an overview of the New York City Health Department’s 2016 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
In recognition of Liver Cancer Awareness Month, Gilead Sciences is excited to share that you can now watch BE ABOUT IT – the documentary highlighting the impact of chronic hep B on the Asian American community – on the Gilead YouTube channel!
Project SUCCEED is a comprehensive HCV care coordination program which links people of color who are co-infected with HIV and HCV to hepatitis C care and treatment.
We are pleased to announce the establishment of Hep Free NYC Community Health Workers (CHWs) Committee. Our purpose is to work toward ways to make the roles of CHWs sustainable and rewarding for both CHWs and the communities they serve.
On August, 7th Governor Cuomo announced a first-in-the-nation program to provide no-cost or lower-cost naloxone at pharmacies across New York.
US FDA advisory panel votes 12-1 in favor of recommending 2-dose Hep B vaccine for approval in immunizing adults aged 18 and older.
City Council demonstrated its commitment to hepatitis elimination by continuing support for the Viral Hepatitis Initiative, which has improved health care access for over 8,000 New Yorkers at risk for or living with hepatitis B or C, and trained over 800 clinical providers.
Presentations include the Statewide Hep C Elimination Plan, Accomplishments and Next Steps for Project INSPIRE, and NYC Policy and Advocacy Updates.
NVHR is seeking a Research Assistant for the “Hepatitis C – It’s About More Than Liver Disease” project.
The Manager, Drug User Health plays an essential role in supporting NASTAD’s technical assistance, capacity building, and advocacy work to promote the health of people who inject drugs (PWID).
The NYS Department of Health has released new guidelines on screening, diagnosis, and treatment of chronic hepatitis C.
World Hepatitis Day takes places every year on July 28 and brings the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change.
July 25th 2017 is the 5th Annual National African American Hepatitis C Action Day. This day provides an opportunity to promote hep C prevention, testing, and treatment messages.
The report identifies new opportunities for preventing transmission and recommends steps to ensure people are tested, treated, and/or cured of hepatitis.
HOPE is a coalition of young people engaging in outreach and education to prevent the spread of Hep C among their peers.
Check out the Hep Free NYC 2016 Annual Report for an overview of the great work we did in 2016.
Wednesday May 10, 2016 11 AM-12 PM Steps of City Hall, NYC (located in City Hall Park) Join us to commemorate May Hepatitis Awareness Month, National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day. Raise awareness for testing, access and treatment! The theme this year is “Stand Up And Help End Hep” Bring posters and your organization’s banners! Invite … Continue reading Hep Free NYC Awareness Event on the Steps of City Hall
The HOPE intern program is a network of college students working to prevent drug addiction and Hep C among youth.
On February 7, 2017, government representatives; medical providers; harm reduction and social service providers; and community advocates came together in Albany for the nation’s first Hep C Elimination Summit.
Committee members educate the public about Hepatitis through presentations, tabling at health fairs, and distribution of resources throughout at-risk communities.
Find resources, testing, and medical care for those who are co-infected with HIV and Hep C.
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
Most states continue to impose discriminatory Hep C medication coverage restrictions in opposition to guidance from the Centers for Medicare & Medicaid Services and AASLD.
Project INSPIRE is a comprehensive hepatitis C care coordination program in NYC, now enrolling until February 2017.
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
Several programs in NYC offer HepCap, which covers the cost of Hep C medical care for eligible patients.
The goal of the Check Hep C Patient Navigation Program is to link NYC residents living with Hep C to medical care.
The goal of the Check Hep B Patient Navigation Program (Check Hep B) is to link New York City residents living with Hep B to medical care.
The goal of the NYC Hep C Peer Navigation Program is to prevent new Hep C infections and navigate NYC residents at risk for Hep C through testing and medical care.
The NYC Health Dept Viral Hepatitis Program facilitated a favorable new Hep C medication contract for NYC Inmates, tripling the number to be treated.
The NYC Health Dept Immunization Clinic (Fort Greene) offers free Hep B vaccines to patients who are uninsured.
Health Department Releases Report On Hepatitis Surveillance And Programs In New York City, Launches Ad Campaign To Promote New Health Care Services For People Living With Viral Hepatitis
The Centers for Medicare and Medicaid Services (CMS) made the final decision to cover screening for hepatitis B infection at no cost to individuals entitled to benefits under Medicare Part A or enrolled in Medicare Part B.
People living with hepatitis B should be screened for liver cancer every six months and people with Hepatitis C and cirrhosis should be screened every six months. Recommended screening is through ultrasound.
The report presents data on Hep C in syringe exchange programs in NYC.
The Mission of the Viral Hepatitis Strategic Plan is to outline a systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
On World Hepatitis Day 2016, hundreds of New Yorkers participated in educational forums, social media campaigns and free hepatitis screenings.
The objective of the survey is to understand how coverage restrictions on hepatitis C treatment affect patients access to treatment, more specifically Medicaid beneficiaries nationwide.
The NYS Attorney General’s office requests that all patients, their doctors, or their representatives make a call to Health Care Bureau’s toll-free Helpline or fill out a complaint form if they feel they have been wrongly denied coverage for their Hep C treatment medications.
Mary T. Basset, NYC Health Commissioner, wrote a letter to CMS in support of Medicare coverage of Hepatitis B screening.
The New York State Hepatitis C Coalition has launched a website at www.HepCNewYork.org. With this new website the coalition will be easier to find, contact, and join.
The following organizations provide Hepatitis B or C Testing in NYC in the community or ‘in the field.’ Please contact these organizations to refer for testing or to collaborate on special events.
Study shows that two out of five Bronx residents who test positive for hepatitis C are undiagnosed. The Health Department’s Viral Hepatitis Program offers free resources to support health care providers in hepatitis B and C screening and care.
World Hepatitis Day provides a platform for people to speak out, be engaged and take action to ensure global commitments are met and viral hepatitis is eliminated by 2030.
The National African Immigrant and Refugee HIV/AIDS and Hepatitis Awareness Day is a day aimed toward bringing both national and local attention to the highly prevalent health issues of HIV/AIDS and viral Hepatitis in African Immigrant and Refugee population in the US.
Check out the Hep Free NYC 2015 Annual Report to read about all the exciting events that took place in 2015!
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
Over 500 Hep Free NYC LGBTQ Resource Cards were passed out during LGBTQ Pride.
July 25th is the 4th Annual National African American Hepatitis C Action Day (NAAHCAD). The National Black Leadership Commission on AIDS, Inc. invite organizations to support the day by signing-on to host activities in their City on or leading up to July 25, 2016. As a national partner, your participation will help to ensure the success and impact … Continue reading National African American Hep C Action Day – July 25 2016
The NYC Health Dept recognized National Hepatitis Awareness Month with a recent press release.
Join us to commemorate National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day.
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
New York State Attorney General Eric Schneiderman announced a major agreement with seven health insurance companies to eliminate restrictions on coverage for Hepatitis C treatment.
The CDC and HHS Report states that Hep B and C could both be eliminated as public health problems in the U.S. but would take considerable will and resources.
Responsible for the yellow color in curry, turmeric helps protect your liver from excessive fat and excessive stress.
A new Epi Data Brief Neighborhood Poverty and Infectious Diseases: Health Disparities in NYC found that New Yorkers residing in very high poverty census tracts were more likely to be diagnosed with Hep B and C.
The NYS attorney general has asked 16 health insurance companies for information on their coverage of Hepatitis C treatments, amid concerns that some companies are restricting coverage of the medications.
The Department of Veterans Affairs will now treat all veterans with Hep C, regardless of stage of liver disease.
FDA Expands Daklinza/Sovaldi Approval to Include Treatment of Hep C Genotype 1
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Effective July 1st, 2015, patients who are insured and who do not meet their payers coverage criteria will no longer be eligible for support via Gilead’s Hep C Patient Assistance Program.
A study that tested 861 suburban heroin users admitted to Princeton House, an inpatient treatment center, found that 44 percent tested positive for Hepatitis C. Nearly two-thirds were under the age of 35.
A NYC plan includes the new “Direct Access” health initiative to provide reliable and coordinated access to affordable care for immigrants who are excluded from federal and state support.
The Medicaid Fee For Service formulary has added Daklinza and Technivie as non-preferred drugs for HCV.
Everywhere But Safe is a documentary film about public injection drug use in urban and rural New York. The film includes perspectives of people who inject drugs, public health professionals, and government officials. It lends a frame to create healthier communities and consider the role of Safer Injection Facilities in harm reduction, overdose prevention and control … Continue reading Video | Everywhere But Safe: Public Injecting in New York (Sawbuck Productions)
On October 5, 2015 FDA approved revisions to the Olysio (simeprevir) label to include dosing recommendations for the treatment of HCV/HIV-1 coinfection and to expand the indications and usage to include genotype 4 infection. The recommended dosage regimens and treatment duration for genotype 1 and HCV/HIV-1 co-infected patients was added to the following table: Table … Continue reading FDA approves revisions to the Olysio (simeprevir) label, including dosing recommendations
On September 23, 2015, the NYC Health Commissioner wrote to Representative Nita Lowey in support of recent Congressional action to modify the syringe access funding rider included in the House FY 16 Labor, Health and Human Services, Education and Related Agencies (LHHS) Appropriations bill. Representative Lowey’s leadership in modifying the ban on federal funding for syringe access programs … Continue reading NYC Health Commissioner Wrote Letter Supporting Federal Funding for Syringe Exchange
NY1 covered World Hepatitis Day 2015, with a focus on Hep C in the Bronx and the Project INSPIRE Hep C Care Coordination program, in the segment on their English and Spanish language channels.
HepCAP serves New York State residents infected with Hep C who are uninsured to access medical services.
As President, I am committed to advancing the fight against viral hepatitis. The Affordable Care Act has increased access to quality, affordable health care. BY THE PRESIDENT OF THE UNITED STATES OF AMERICA Around the world, doctors, medical researchers, and other professionals dedicated to health care and public health are working hard every day to … Continue reading Presidential Proclamation | World Hepatitis Day 2015
On July 24, 2015, FDA approved DAKLINZA (daclatasvir) a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV genotype 3 infection. DAKLINZA is available as a 30 mg and 60 mg tablet. DAKLINZA is the first drug that has demonstrated safety and efficacy to treat genotype 3 … Continue reading FDA Approves Daklinza in Combination with Sofosbuvir for HCV Genotype 3 Infection
See in PDF: World Hep Day 2015 Press Release Contact: Sue Preziotti, 917-647-1590 firstname.lastname@example.org Free Screenings, Vaccinations, Health Fairs to Mark 6th Annual World Hepatitis Day in NYC (July 28) Nearly 250,000 in NYC Infected with Hepatitis B or C Viruses, which Cause 4,000 Deaths a Day Worldwide New York, NY, July 24, 2015 – The Hep Free … Continue reading Press Release | 2015 World Hepatitis Day (Hep Free NYC)
Source: Defining the Experienced Hepatitis C Provider, New York State Department of Health AIDS Institute, June 2015 Transformative new treatments for hepatitis C virus (HCV) will greatly expand the number of patients in New York State who can be treated successfully. This expansion promises to reduce morbidity, mortality, and the incidence of HCV transmission, but it … Continue reading NYS Department of Health Defines HCV Experienced Provider
Worldwide 400 million people are living with hepatitis B or C. Every year 1.4 million people die from viral hepatitis and yet all of these deaths could be prevented. With better awareness and understanding of how we can prevent hepatitis we can eliminate this disease and save 4,000 lives a day. Events happening in NYC: … Continue reading Get Involved! World Hepatitis Day 2015 NYC
Dear Colleague: I am delighted to present the new National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention: Strategic Plan through 2020. This Plan updates the Center’s current strategic plan and serves as a blueprint for achieving our vision of a future free of HIV, viral hepatitis, STDs, and TB. It will guide activities … Continue reading CDC Viral Hepatitis Strategic Plan – 2020
As of May 2, 2015, 27 cases of hepatitis A infection have been reported among United States travelers to Tulum, Mexico. CDC has issued a Level 1 Travel Advisory recommending hepatitis A vaccination for all previously unimmunized individuals who plan to travel to Tulum, Mexico. To date, 11 cases have been reported among New York … Continue reading NYC Health Dept Alert | Hep A Associated with Travel to Tulum, Mexico
May is Hepatitis Awareness Month! National Hispanic Hepatitis Awareness Day | National Hepatitis Testing Day Join us for a citywide Hep Free NYC Awareness Event Steps of City Hall – Thursday, May 14th, 10-11AM To learn more or get involved, contact the Hep Free NYC Awareness Day Planning Group Join us on the Steps of City … Continue reading Press Conference | Hep Free NYC Awareness Event 2015
This is an official CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network April 24, 2015, 11:00 ET (11:00 AM ET) CDCHAN-00377 Summary The Indiana State Department of Health (ISDH) and the Centers for Disease Control and Prevention (CDC) are investigating a large outbreak of recent human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). … Continue reading CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)
Save the date for the 2015 US Conference on African Immigrant Health to take place on Call for abstracts are coming up soon. For more info, contact Margaret Korto at MKorto@minorityhealth.hhs.gov or Gary Gant at GGant@hrsa.gov.
The World Health Organization (WHO) issued its first-ever guidance for the treatment of chronic hepatitis B. Worldwide, some 240 million people have chronic hepatitis B virus with the highest rates of infection in Africa and Asia. People with chronic hepatitis B infection are at increased risk of dying from cirrhosis and liver cancer. Key recommendations include: … Continue reading World Health Organization Issues 1st Hep B Treatment Guidelines
At the Feb 26, 2015 NYSDOH Drug Utilization Review Board meeting, the board voted to approve Viekira Pak as its preferred drug for persons chronically infected with HCV and enrolled in FFS Medicaid. Viekira Pak will be available for all chronically infected persons regardless of disease severity. This drug is also FDA approved for HIV … Continue reading NYS DOH approves Viekira Pak as preferred drug for Hep C for FFS Medicaid beneficiaries
To view the full NYC Hepatitis B and C Surveillance Report click here See also NYC Health Department Online Data Portal EpiQuery. Click here
Community Representative Nominations for the HCV Guidance Panel Needed The AASLD and IDSA in collaboration with IAS–USA HCV Guidance Panel is seeking an additional community representative to serve on the panel that drafts the Recommendations for Testing, Managing, and Treating Hepatitis C. Community representatives serve a 2 to 3 year term, similar to the scientific … Continue reading Nominations Needed for AASLD/IAS-USA HCV Guidance Panel
The NYS Department of Health Drug Utilization Review Board (DURB) has added Harvoni to the NYS Medicaid Fee-for-service formulary. This is an expected outcome since the November 20th approval of Harvoni by the NYS DURB. Below is an excerpt from a letter by Colleen Flanigan, Director of Viral Hepatitis at the NYS Dept. of Health. As … Continue reading Harvoni Added to NYS Medicaid Fee-for-service Formulary
Dr. John Ward, Director of the Division of Viral Hepatitis at the Centers for Disease Control and Prevention, authored an article entitled “Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan” at blog.AIDS.gov on January 9th. The Viral Hepaitits Prevention Coordinators (VHPCs) program began in … Continue reading Viral Hep Coordinators are Vital. CDC AIDS.gov Blog
A new hepatitis C medication, Viekira Pak, was approved today by the U.S. Food and Drug Administration (FDA). AbbVie, who markets the drug, has not immediately released the price of the new all-oral Hep C medication which will now rival Harvoni and Sovaldi from Gilead Sciences. Harvoni and Sovaldi have generated controversy over their high-price tags and … Continue reading FDA Approves Viekira Pak to Treat Hep C
Cost of Hepatitis C drug means major state Medicaid spend. Capital. New York state’s Medicaid program spent $193.2 million during the first six months of 2014 on Sovaldi, the controversial Hepatitis C drug that carries an $84,000-per-patient price tag. In the first six months of 2014, 6,911 prescriptions were written for Sovaldi for a 12-week … Continue reading Cost of Hep C Drug Means Major State Medicaid Spend
New Regional Board Members Our Executive Board is vital to the governance of the Alliance and, crucially, to provide representation for our patient groups on a regional level. Following a largely contested election, we are happy to now announce our new Regional Board Members for 2014-2016. Our voting members have spoken and votes have been … Continue reading Congratulations! Dr. Su Wang – New Board Member @ World Hep Alliance
Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $150,360. Olysio in combination with Sovaldi is the second Hepatitis C combination treatment regimen … Continue reading Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment
AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations Check Hep C was implemented in 2012-2013 by the New York City Department of Health and Mental Hygiene (DOHMH) as a year-long demonstration project designed to increase screening, diagnosis, and linkage to care for persons chronically infected with … Continue reading AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations
On Veteran’s Day, Boom!Health offered rapid HCV testing with specific outreach to veterans and baby boomers. The testing was offered at two of their locations: Harm Reduction Center, 226 East 144th St, Bronx, NY 10451 Prevention Center, 953 Southern Blvd, 2nd Floor, Bronx, NY 10459 Below is a report sent through their mailing list. Go to www.boomhealth.org and scroll to the … Continue reading BOOM!Health Promotes HCV Screening for Veterans
The American Liver Foundation (ALF) has announced a special educational campaign commemorating October as Liver Cancer Awareness Month.
Today, the FDA approved Harvoni, a fixed-dose combination pill of ledipasvir and sofosbuvir produced by Gilead Sciences, Inc. The following information was released by the FDA along with the approval. The complete product label will be available soon at DailyMed or at Drugs@FDA. Also see: FDA Press Release on the approval, and Harvoni Patient Information On October … Continue reading Harvoni: FDA Approved – Combo Pill for Hep C Treatment
The 2014 NYC HCV Research Consortium was held at The Rockefeller University on September 29, 2014. The consortium brought together providers, researchers, and community advocates to discuss the current state of hepatitis C research and practice in New York City and determine future priorities. Please review materials and presentations from the consortium below. We will … Continue reading 2014 NYC Hep C Research Consortium Report
The White House Initiative on Asian Americans and Pacific Islanders and Data.gov are launching a new federal website that aims to consolidate data on the Asian American, Native Hawaiian, and Pacific Islander community: Data.gov/AAPI.
The listed NYC pharmacies provide Hep B & C Treatment Adherence Programs. These local specialty pharmacies can help with ordering medication, counseling patients about use, and providing treatment adherence support.
See original post here. Presidential Proclamation — World Hepatitis Day, 2014 WORLD HEPATITIS DAY, 2014 – – – – – – – BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION Around the world, one in twelve people are living with viral hepatitis. In the United States, millions of Americans are infected with … Continue reading Presidential Proclamation | World Hepatitis Day 2014
Summary: The NYC Department of Health has announced the receipt of a new grant from the Federal government to improve treatment for hepatitis C. The grant will allow the Health Department, in conjunction with the Fund for Public Health in New York, Mount Sinai School of Medicine, Montefiore Medical Center, Weill Cornell Medical College, VNSNY Choice … Continue reading Press Release | Project INSPIRE – CMS funded Innovations Award (NYC Health Dept)
The Albert Einstein College of Medicine Division of Substance of Abuse invites you to the Bronx Premiere of “The Fix”!
The Council of the City of New York Office of Communications City Hall New York, NY 10007 July 21, 2014 Contact: Sam Spokony [Chin]: 212-788-7259, email@example.com Jefferey LeFrancois [Johnson]: 212-564-7757, firstname.lastname@example.org Jonathan Chung [Koo]: 718-888-8747, email@example.com COUNCIL MEMBERS CHIN, JOHNSON AND KOO JOIN HEALTHCARE PROVIDERS AND ADVOCATES TO LAUNCH FIRST-EVER NYC HEPATITIS B AWARENESS WEEK … Continue reading Press Release | 2014 NYC Hep B Awareness Week Press Conference
Bill A9124A will enable New York State nurse practitioners and physicians to administer tests to determine the presence of hepatitis C in patients without a patient-specific standing order. Background: The New York City Department of Health and Mental Hygiene estimates that 146,500 individuals are living with chronic hepatitis C in NYC, and approximately half are unaware … Continue reading NYS Hep C Testing Bill (A9124A): In Assembly
CDC National Prevention Information Network is hosting a Twitter chat on July 17 in preparation for National African American Hepatitis C Action Day. Please see the invitation below for details. Please join CDC National Prevention Information Network for an upcoming Twitter chat on Thursday, July 17, 2014, from 2PM – 3PM ET. We will … Continue reading Twitter Chat | CDC Q&A: National African American Hepatitis C Action Day
Newly released: NYC Dept of Health Commissioner Hep C Dear Colleague Letter NYC DOHMH COH Hep C Dear Colleague Letter 2014 (pdf) June 2014 Dear Colleague: We are at a turning point in the fight against hepatitis C virus (HCV) infection. Across the nation, HCV now causes more deaths annually than HIV and remains a leading … Continue reading NYC Commissioner of Health | Hep C Dear Colleague Letter (2014)
Thank you to those who have already submitted abstracts to the 2014 NYC HCV Research Consortium. Fortunately, the abstract submission window will remain open for a few more days. The updated abstract submission deadline is August 4 at 12:00 PM. Abstracts should be submitted according to the consortium guidelines for abstract submission to firstname.lastname@example.org. Please mark your calendars … Continue reading Updated! Call for Abstracts | NY Hep C Research Consortium – Sept 29
SIGN UP HERE (Volunteers get a free World Hepatitis Day t-shirt!) CALLING ALL VOLUNTEERS!VOLUNTEER FOR WORLD HEPATITIS DAY- Monday, July 28th Join Team HBV on July 28 as we raise awareness on World Hepatitis Day! The day will be split into a two-part event: Part A (10AM-11AM): 5 Borough Viral Hepatitis Awareness Event Locations: Brooklyn: … Continue reading World Hepatitis Day is July 28th! Get involved!
The U.S. Preventative Services Task Force has updated their 2004 recommendation on hepatitis B screening and now recommends screening for hepatitis B virus (HBV) in non-pregnant adolescents and adults at high risk for infection, which may include: Those born in countries where the prevalence of HBV infection is 2% or greater Those born in the … Continue reading USPSTF Recommends Hep B Screening in High Risk Individuals
In recognition of Hepatitis Testing Day, May 19, The AIDS Institute has released a Hepatitis C (HCV) Testing Coverage Guide to assist health care providers with navigating each of the major healthcare payers’ coverage options for preventive services, specifically for HCV screening. Additionally, the guide will help educate people on the need to get tested … Continue reading AIDS Institute Releases Hep C Testing Coverage Guide
On May 15, we met at the Steps of City Hall to raise awareness and in recognition of National Hepatitis Awareness Month during May, as well as National Hispanic Hepatitis Awareness Day on May 15, and National Hepatitis Testing Day on May 19. Where: Steps of City Hall, New York, NY (4, 5, 6 or R … Continue reading Press Conference | Hep Free NYC Awareness Event 2014
May is Hepatitis Awareness Month! Community partners are holding events across NYC this month, to raise awareness and provide free testing to those at risk for viral hepatitis. Find an event in your community! Look for updates on this page and our calendar. Join us on May 15th for a Press Conference on the … Continue reading Hepatitis Awareness Month: May 2014 Events
New Website Launched on Health System Changes On May 5, CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) launched the Prevention of HIV/AIDS, Viral Hepatitis, STDs, and TB Through Health Care Website, an online resource to help state, local, and tribal public health agencies, community-based organizations, and other partners leverage changes in the … Continue reading CDC Launches “Prevention Through Health Care” Website
The Hep Free NYC Patient Navigator Network is a committee of the NYC Hep B Coalition & Hep C Task Force and serves to identify and make contact with professionals who navigate patients with Hep B or C through the health care system.
Watch the new Hep C Testing Law Video Developed by the NYS DOH Clinical Education Initiative (July 2015) Background on the Law Effective January 1, 2014, the NYS Hepatitis C Testing Law. 2171 requires healthcare providers to offer hep C test to baby boomers. The law requires full diagnostic testing for those who screen anti-body positive and either … Continue reading NYS Hep C ‘Baby Boomer’ Testing Law
The New York State Department of Health provides programs that serve populations at risk for Hep C free HCV test kits and controls.
Nirav R. Shah, M.D., the Commissioner of the New York State Health Department has released a Dear Colleague letter announcing the new Hepatitis C Testing Law. (Section 2171) The new law, which will take effect January 1st, 2014, mandates that every individual born between 1945 and 1965 be offered a Hepatitis C screening in either … Continue reading NYS COH Sends Dear Colleague Letter on Hep C Testing Law
HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Poster ID Week 2013 Conference
The NYC Hep C Research Consortium 2013 September 26th, 2013 Agenda & List of Poster Presentations: NYHCVRC_Agenda 2013 (PDF) Compendium of Abstracts: NYHCVRC Abstract Book (PDF) For more information on this event, contact: Eric Rude (email@example.com)
TOP NEWS Health Department Announces Plan to Combat Hepatitis C The NYC Health Department today released the City’s first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS. In Hepatitis C in New York City: State of the Epidemic and Action … Continue reading NYC Health Department Announces Strategic Plan to Combat Hepatitis C
In Celebration of Recovery Month 2013 Announcing the 2013 In My Own Words… Essay Contest! > Please help spread the word! You can easily add a link to your webpage to help get the word out about this year’s essay contest. Click here to find out more. Please consider forwarding this email to your contacts … Continue reading Hep C In my Own Words Essay Contest
Below is a sign-on letter urging HHS Secretary Sebelius to initiate a Medicare national coverage determination process for adding hepatitis C screening to Medicare. While the USPSTF “B” grade ensures that HCV testing will not have cost-sharing for Medicare beneficiaries, the coverage determination process is necessary for adding any service. This process can take from … Continue reading Sign-on Letter Urging HHS Secretary Sebelius to Add Hepatitis C Screening to Medicare
The NYC Hep C Task Force & Hep B Coalition created a workgroup in 2013 to address hepatitis in the Caribbean communities of NYC. Goals Current Activities Contact
Each year the President of the United States acknowledges World Hepatitis Day and states urgency to prevent, diagnose, and treat this disease.
Join fellow hepatitis advocates on July 28th at Noon in Times Square for World Hepatitis Day! Sign up here: http://goo.gl/qCdw2 World Hepatitis Day NYC – Times Square – Noon on July 28th!
Click Here to View the Newsletter Online: May 2013 NYC Hep ABC Newsletter: Hep Awareness Month!
MEDIA ADVISORY Contact: John Hellman Tel: 646-377-6115; firstname.lastname@example.org New York City Leaders and Federal Officials Call for Action to Address the Impact of Viral Hepatitis What: Elected officials, community leaders and public health officials will announce free and low cost hepatitis screenings and unveil a new PSA campaign in New York City, San … Continue reading Media Advisory | Hep Awareness Month Press Conference 2013
Viral hepatitis is highly endemic in many parts of Africa (defined by the CDC as 8-20%), and prevalence rates among Africans living in the U.S. are similar to rates in Africa. There is a large African-born population living in the United States, specifically in New York City. However, there is a lack of public health … Continue reading Coalition against Hepatitis in People of African Origin (CHIPO) NYC
Question: A HCV+ patient who has cirhossis and may need a liver transplant was denied Medicaid due to $300 surplus from unemployment insurance. He can not afford to purchase private health insurance, and definitely needs medical care that is more expensive than he can pay out of pocket. What can he do? Answer: Your patient … Continue reading A HCV patient who has cirhossis
Question: My patient is an undocumented immigrant and needs care for his hepatitis, where can he go to get care he can afford? Is he at risk for deportation if he goes to a government hospital? Answer: Public Hospitals (HCC) and Federally Qualified Health Centers (FQHC) must provide care regardless of ability to pay. Medical … Continue reading My patient is an undocumented immigrant
Question: My client cannot afford to pay Medicare Part D and therefore has no prescription coverage. Is there support available for patients who need help covering the premium for Medicare Part D? Are there resources they can apply for in NY State? Answer: They should contact the HIICAP program for assistance. In NYC they can be … Continue reading My client cannot afford to pay
Question: The Prior Authorization for Hep C medications is is extremely difficult! Is there any resource that can help reduce the confusion and time? Answer: Many providers have noted this problem. Try using this service: CoverMyMeds helps physicians and pharmacists complete Prior Authorization and other insurance coverage determination forms for any drug and almost all drug … Continue reading The Prior Authorization for Hep C
Question: My client needs case management and our program doesn’t have funding for a case manager for a Hepatitis B or C mono-infected patient. Is there any resource that can help? Answer: Most health insurance plans, including Medicaid Managed Care plans, have a ‘Care Management’ service. Call the plan on the plan using the member services phone number … Continue reading My client needs case management
Dear Fellow Researcher, The Planning Committee would like to invite you to participate in the 2013 Meeting of the New York Hepatitis C (HCV) Research Consortium. As with our previous meetings, we intend to highlight research in all fields of HCV study occurring in the New York area, a major center of research activity and … Continue reading Call for Abstracts – 2013 NY Hep C Research Consortium
Click here to view the full: April 2013 NYC Hep ABC Newsletter
View as PDF: Dear Colleague COH-Hep C Screening 2013 April 2013 Dear Colleague: I am writing to ask your help with diagnosing and treating hepatitis C, an increasing cause of illness and death among New Yorkers. Across the nation, hepatitis C virus (HCV) now causes more deaths annually than HIV infection. Because new drug regimens … Continue reading Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)
The National Association of Community Health Centers would like to have more HBV research posters represented at the Community Health Institute Conference (Aug 23-27 in Chicago), therefore we are asking any health centers, networks, PCAs, researchers, academics, and others to submit online an ABSTRACT on your HBV research by Friday May 3rd. If selected you … Continue reading Submit HBV Abstract | Community Health Institute Conference (Aug 23-27 in Chicago) Submission Deadline: May 3rd
The March 2013 NYC Hep ABC Newsletter provides the latest information, resources and opportunities to organizations & advocates working to improve the health of people affected by Hep A, B & C in NYC. View this email in your browser
To view the full February 2013 NYC Hep ABC Newsletter click here: http://eepurl.com/uW59P
With support from the NYC Hepatitis B Coalition, Team HBV NYC seeks to: Identify High School, College, and Graduate Students concerned about hepatitis B in their communities who want to take a leadership role in generating awareness and improving health outcomes in NYC. Establish a network of student leaders at educational institutions throughout NYC to … Continue reading Team HBV NYC
To view the full newsletter, click here: http://eepurl.com/tsVUv
December 2012 NYC Hepatitis ABC Newsletter – Click here to view online! http://eepurl.com/sONsn
See report displaying disease co-occurrence of HIV/AIDS, Hepatitis, STDs and Tuberculosis in NYC neighborhoods.
Click here to view the November 2012 Newsletter online: http://eepurl.com/rcpeD
OCTOBER 2012 NYC Hep ABC Newsletter NYC Department of Health | Office of Viral Hepatitis Coordination Click to view online: http://eepurl.com/qd9B9
September 2012 NYC Hepatitis ABC Newsletter The NYC Hepatitis ABC Newsletter is designed to provide the latest information, resources and opportunities to NYC organizations & advocates working to improve the health of people affected by Hepatitis A, B & C. View it in your browser!
☼ August 2012 | NYC Hepatitis ABC Newsletter NYC Department of Health | Office of Viral Hepatitis Coordination View Online
Battelle Centers for Public Health Research and Evaluation are working with the Centers for Disease Control and Prevention (CDC) to conduct a field assessment of a comprehensive counseling and testing manual for Hepatitis C (HCV). With the expansion of HCV testing, and the introduction of the rapid HCV antibody test, Hepatitis C counseling and testing … Continue reading Request for Sites to Field Test CDC Hep C Counseling & Testing Manual
view original newsletter online! July 2012 ☼ NYC Hepatitis ABC Newsletter NYC Department of Health – Office of Viral Hepatitis Coordination Upcoming Events Hep B & C Workshop & Screening for the Ghanaian Community in the Bronx. 7/6/12 and testing on 7/13/12 (2-5 pm). Location: Bronx Islamic Cultural Center: 50E Tremont Avenue, Bronx NY 10453. RSVP: Yahuza Siba, MD, African … Continue reading July 2012 ☼ NYC Hepatitis ABC Newsletter
The NYC Hepatitis ABC Newsletter is designed to provide the latest information, resources and opportunities to organizations & advocates working on viral hepatitis and related issues. Is this email not displaying correctly? View it in your browser. June 2012 ☼ NYC Hepatitis ABC Newsletter NYC Department of Health – Office of Viral Hepatitis … Continue reading June 2012 NYC Hepatitis ABC Newsletter
The NYC Hepatitis ABC Newsletter is designed to provide the latest information, resources and opportunities to organizations & advocates working on viral hepatitis and related issues. View online NYC Hepatitis ABC Newsletter NYC Department of Health – Office of Viral Hepatitis Coordination Upcoming Events Coalition Meetings NYC Hepatitis B Coalition Meeting. May 10th (3-5 PM). … Continue reading May 2012 Hepatits ABC Newsletter